Updated rapid risk assessment on Ebola in West Africa
The latest assessment includes additional details regarding risk of onward transmission in the EU, the evolution of infectiousness during the course of the disease, more detailed options for risk reduction in healthcare settings and an update of the global number of cases.
ECDC has updated its rapid risk assessment on Ebola virus disease in West Africa.
The main changes to the report include additional details regarding:
- the risk of onward transmission in the EU when an EVD patient appears in the EU;
- the evolution of infectiousness during the course of the disease and its implications regarding risk periods for transmission;
- more detailed options for risk reduction in healthcare settings;
- an update of the global number of cases.
In the week between 5 October and 12 October the World Health Organization (WHO) reported an additional 600 cases and 461 deaths of Ebola virus disease. The outbreak of Ebola virus disease (EVD) in West Africa has now reached almost 9000 cases, including almost 4 500 deaths, as of 12 October 2014. The outbreak has affected seven countries to date: Guinea, Liberia, Sierra Leone, Nigeria, Senegal, Spain and USA. Several European countries have also received medically evacuated patients.
On 6 October, the Spanish authorities reported a confirmed case of Ebola virus disease (EVD) in a healthcare worker who cared for a repatriated patient with Ebola infection. On 14 October a second healthcare worker in Dallas, Texas tested positive for Ebola virus after having cared for the first case in the USA.
There are no significant changes in the assessment of risk to Europe in comparison to previous ECDC rapid risk assessment.
The risk assessment concludes that, if the outbreak continues in West Africa with the current dynamics and without effective measures in place, a potentially explosive evolution could be expected, with serious consequences for the region.
The risk of Ebola virus arriving in the EU will not be eliminated until transmission stops in West Africa. This underlines the importance of bringing the outbreak in West Africa under control.
Read the Rapid Risk Assessment: Outbreak of Ebola virus disease in West Africa - Seventh update, 17 October 2014
Ebola treatment trial: two drugs identified as more effective
14 Aug 2019 - Two out of the four drugs tested in a multi-drug randomised control trial have been found more effective in treating Ebola, the World Health Organization announced on Monday. The Data and Safety Monitoring Board, an independent body that has been reviewing interim safety and efficacy data, has therefore recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114, in what is being considered an extension phase of the study.
Ebola outbreak in the Democratic Republic of the Congo: ECDC updates assessment for Europe
19 Jul 2019 - After the Ebola virus disease outbreak was declared a Public Health Emergency of International Concern on 17 July 2019, ECDC updated its risk assessment for the EU/EEA on the on-going outbreak: the overall risk of introduction and further spread of the Ebola virus within the EU/EEA remains very low.
Epidemiological update: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo
25 Jan 2019 - Since the beginning of the outbreak and as of 23 January 2019, according to the Ministry of Health of the Democratic Republic of the Congo, there have been 715 Ebola virus disease cases (666 confirmed, 49 probable), including 443 deaths (394 in confirmed and 49 in probable cases).